Systemic Adjuvant Treatment of T1a and T1b NOMO HER2+Breast Carcinomas; an AERIO/UNICANCER Study.

被引：0
|
作者：
Peron, J. [1 ]
Vano, Y. [1 ]
Frenel, J-S [1 ]
Wassermann, J. [1 ]
Albiges, L. [1 ]
Rodrigues, M. J. [1 ]
Cottu, P. H. [1 ]
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-18-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-18-03
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Galectin-3 and CD44v6 expression in early (T1a and T1b) breast cancer
    Jaratli, H
    Ali, I
    Witkiewicz, A
    Khan, A
    MODERN PATHOLOGY, 2002, 15 (01) : 39A - 39A
  • [42] Is CAD Able to Assist in the Detection of Subtle Breast Findings - Lobular Cancers, and T1a/T1b Masses in Dense Breasts?
    Leichter, Isaac
    Gallimidi, Zahava
    Heyman-Reiss, Asnat
    Merlet, Nicolas
    Ratner, Eli
    Abramov, Menachem
    Stainvas, Inna
    Lederman, Richard
    DIGITAL MAMMOGRAPHY, 2010, 6136 : 474 - +
  • [43] Biological and Prognostic Role of Tumor Size (T1a, T1b, T1c) in Stage I Breast Cancer (Experience of International Cooperation)
    Kolyadina, I. V.
    Poddubnaya, I. V.
    van de Velde, Cornelis J. H.
    Kuppen, Peter J. K.
    Bastiaannet, E.
    Komov, D. V.
    Karseladze, A. I.
    Ermilova, V. D.
    Vishnevskaya, Y. V.
    Frank, G. A.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2014, 6 (03) : 28 - 34
  • [44] Galectin-3 and CD44v6 expression in early (T1a and t1b) breast cancer
    Jaratli, H
    Ali, I
    Witkiewicz, A
    Khan, A
    LABORATORY INVESTIGATION, 2002, 82 (01) : 39A - 39A
  • [45] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    G. Cancello
    P. Maisonneuve
    N. Rotmensz
    G. Viale
    M. G. Mastropasqua
    G. Pruneri
    E. Montagna
    S. Dellapasqua
    M. Iorfida
    A. Cardillo
    P. Veronesi
    A. Luini
    M. Intra
    O. Gentilini
    E. Scarano
    A. Goldhirsch
    M. Colleoni
    Breast Cancer Research and Treatment, 2011, 127
  • [46] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O.
    Scarano, E.
    Goldhirsch, A.
    Colleoni, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 713 - 720
  • [47] Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients
    Wolters, R.
    Ebner, F.
    Janni, W.
    Novopashenny, I.
    Woeckel, A.
    Kreienberg, R.
    Wischnewsky, M.
    Schwentner, Lukas
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 294 (02) : 377 - 384
  • [48] Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients
    R. Wolters
    F. Ebner
    W. Janni
    I. Novopashenny
    A. Wöckel
    R. Kreienberg
    M. Wischnewsky
    Lukas Schwentner
    Archives of Gynecology and Obstetrics, 2016, 294 : 377 - 384
  • [49] T-DM1 Reduces HER2+Breast Cancer Recurrence
    Harper, Kristin
    CANCER DISCOVERY, 2019, 9 (02) : 158 - 159
  • [50] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O. D.
    Scarano, E.
    Pastrello, D.
    Goldhirsch, A.
    Colleoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345